AVDL
Avadel Pharmaceuticals
AVDL
AVDL
79 hedge funds and large institutions have $156M invested in Avadel Pharmaceuticals in 2020 Q3 according to their latest regulatory filings, with 20 funds opening new positions, 25 increasing their positions, 19 reducing their positions, and 15 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more call options, than puts
Call options by funds: $ | Put options by funds: $
more funds holding
Funds holding: →
8.23% less ownership
Funds ownership: 62.4% → 54.17% (-8.2%)
33% less funds holding in top 10
Funds holding in top 10: 3 → 2 (-1)
47% less capital invested
Capital invested by funds: $293M → $156M (-$137M)
Holders
79
Holding in Top 10
2
Calls
$1.12M
Puts
$907K
Top Buyers
| 1 | +$6.84M | |
| 2 | +$1.17M | |
| 3 | +$1.11M | |
| 4 |
Morgan Stanley
New York
|
+$956K |
| 5 |
Acadian Asset Management
Boston,
Massachusetts
|
+$764K |
Top Sellers
| 1 | -$25.3M | |
| 2 | -$8.55M | |
| 3 | -$5.28M | |
| 4 |
APM
Avidity Partners Management
Dallas,
Texas
|
-$3.7M |
| 5 |
B
Bailard
Foster City,
California
|
-$2.37M |